![]()
|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 13, 9475-9481, March 30, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Signaling by Targeting SnoN Oncoprotein for Degradation*

||
||1
From the
Department of Molecular Biology, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan, the
Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, North Carolina 27695-7633, ¶Laboratory of Molecular Genetics, RIKEN Tsukuba Institute, Ibaraki 305-0074, Japan, and ||Solution Oriented Research for Science and Technology, Japan Science and Technology Agency, Japan
Transforming growth factor-
(TGF-
) regulates a variety of physiologic processes through essential intracellular mediators Smads. The SnoN oncoprotein is an inhibitor of TGF-
signaling. SnoN recruits transcriptional repressor complex to block Smad-dependent transcriptional activation of TGF-
-responsive genes. Following TGF-
stimulation, SnoN is rapidly degraded, thereby allowing the activation of TGF-
target genes. Here, we report the role of TAK1 as a SnoN protein kinase. TAK1 interacted with and phosphorylated SnoN, and this phosphorylation regulated the stability of SnoN. Inactivation of TAK1 prevented TGF-
-induced SnoN degradation and impaired induction of the TGF-
-responsive genes. These data suggest that TAK1 modulates TGF-
-dependent cellular responses by targeting SnoN for degradation.
Received for publication, January 30, 2007
* This work was supported by special grants for advanced research on cancer from the Ministry of Education, Culture, and Science of Japan (to K. M.) and by National Institutes of Health Grants GM068812 and AR050972 (to J. N.-T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1S3.
1 To whom correspondence should be addressed: Dept. of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695-7633. Tel.: 919-513-1586; Fax: 919-515-7169; E-mail: Jun_Tsuji{at}ncsu.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Erdogan, A. Pozzi, N. Bhowmick, H. L. Moses, and R. Zent Transforming Growth Factor-{beta} (TGF-{beta}) and TGF-{beta}-Associated Kinase 1 Are Required for R-Ras-Mediated Transformation of Mammary Epithelial Cells Cancer Res., August 1, 2008; 68(15): 6224 - 6231. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kajino-Sakamoto, M. Inagaki, E. Lippert, S. Akira, S. Robine, K. Matsumoto, C. Jobin, and J. Ninomiya-Tsuji Enterocyte-Derived TAK1 Signaling Prevents Epithelium Apoptosis and the Development of Ileitis and Colitis J. Immunol., July 15, 2008; 181(2): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Kim, J. H. Kwak, L. Wang, and M. E. Choi Protein Phosphatase 2A Is a Negative Regulator of Transforming Growth Factor-{beta}1-induced TAK1 Activation in Mesangial Cells J. Biol. Chem., April 18, 2008; 283(16): 10753 - 10763. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |